hackettg

/hackettg

About hackettg

This author has not yet filled in any details.
So far hackettg has created 155 blog entries.

MHRA Class 4 Medicines Defect Notification: Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe (Teva UK Ltd)

MHRA Class 4 Medicines Defect Notification: Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe (Teva UK Ltd) EL(26)A/27 DMRC reference number: DMRC- 39320587 Date issued: 4 June 2026 Teva UK Limited is reporting a labelling error on the carton for Ponlimsi (Denosumab) 60mg Solution for injection in Pre-filled Syringe. The carton states “For application to [...]

The post MHRA Class 4 Medicines Defect Notification: Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe (Teva UK Ltd) appeared first on Community Pharmacy England.

By |June 4th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe (Teva UK Ltd)

Drug Tariff Watch – June 2026

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 June 2026. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – June 2026 appeared first on Community Pharmacy England.

By |May 27th, 2026|Lexpos News|Comments Off on Drug Tariff Watch – June 2026

MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH)

MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH) DMRC reference number: DMRC- 39439934 Date issued: 14 May 2026 Fresenius Medical Care Deutschland GmbH have identified an error in the Braille printed on the outer label. Marketing Authorisation Holder: Fresenius Medical Care Deutschland GmbH [...]

The post MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH) appeared first on Community Pharmacy England.

By |May 14th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH)

Drug Tariff Watch – May 2026

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 May 2026. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – May 2026 appeared first on Community Pharmacy England.

By |April 28th, 2026|Lexpos News|Comments Off on Drug Tariff Watch – May 2026

Drug Tariff Watch – April 2026

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 April 2026. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – April 2026 appeared first on Community Pharmacy England.

By |March 27th, 2026|Lexpos News|Comments Off on Drug Tariff Watch – April 2026